Evaluation of apramycin against spectinomycin-resistant and -susceptible strains of Neisseria gonorrhoeae

Stefan Riedel, Divya Vijayakumar, Gretchen Berg, Anthony D. Kang, Kenny Smith, James E. KirbyJournal of Antimicrobial Chemotherapy 2019 · DOI

Abstract

Apramycin has broad-spectrum, rapidly bactericidal activity against N. gonorrhoeae. Future pharmacokinetic and pharmacodynamic studies will be needed to determine whether apramycin and/or apramycin derivatives hold promise as new therapeutics for N. gonorrhoeae infection.
BibTeX
@article{riedel2019evaluation,
  author = {Stefan Riedel and Divya Vijayakumar and Gretchen Berg and Anthony D. Kang and Kenny Smith and James E. Kirby},
  title = {{Evaluation of apramycin against spectinomycin-resistant and -susceptible strains of Neisseria gonorrhoeae}},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2019},
  doi = {10.1093/jac/dkz012},
}

Loading related content...

Figure